Olaparib and Radiotherapy in Head and Neck Cancer

Clinical trial NCT02229656 · UNKNOWN

Trial details

NCT number: NCT02229656
Sponsor: The Netherlands Cancer Institute
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Laryngeal Cancer Stage II Laryngeal Cancer Stage III Carcinoma, Squamous Cell Head and Neck Neoplasms

Start date: 2014-09-24
Primary completion: 2020-01-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.